Gilead’s Global Tax Strategy
Gilead complies with tax laws in the countries in which we conduct business. We perform governance procedures to ensure compliance and are committed to transparent and constructive relationships with all relevant tax authorities.
UK Gender Pay Report
At Gilead, we strive to create a work environment where differences are valued, and people feel involved, respected and connected. The most recent gender pay report can be found here.
Relationships with Healthcare Professionals and Collaborative Working Projects
Healthcare professionals, other relevant decision-makers and healthcare organisations with whom we work provide valuable, independent and expert knowledge derived from their clinical and management experience. This expertise makes an important contribution to our efforts to improve the quality of patient care, with benefits for individuals and society at large.
Modern Slavery Act Statement
Gilead recognises the seriousness and importance of combatting modern slavery and human trafficking. We are committed to fully understanding and taking all appropriate action to address any slavery and human trafficking risks in our own business and in our supply chains.
Relationship with Patient Organisations and Members of the Public, including Patients and Journalists
Gilead provides support to some patient organisations to help those organisations respond to the needs of the communities they look after. Read the 2021 report below, correct at the time of writing June 2022. The information is subject to change and periodic updates.
Gilead also engages members of the public for certain contracted services including speaking at meetings, assistance with training, writing articles and/or publications, participating in advisory boards, advising on the design etc of clinical trials and participating in market research where such participation involves remuneration and/or travel.
Read the reports below, correct at the time of writing June 2023. The information is subject to change and periodic updates.